Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Top Pharma List methodology page

  • The Top Pharma List is based on data provided by research and consulting firm GlobalData.
  • The current version of the data ranks companies based on information from GlobalData Pharma Intelligence Center’s Sales Analytics Database, as shown on July 7, 2017.
  • Figures for the period 2018-23 are a forecast, but only show the performance of those companies featured in the 2017 ranking.

US/Japan/Europe Rx

  • These lists rank the top companies based on geographic-specific sales.

Products

  • Product sales are mapped to the parent company, rather than subsidiary companies, as they are reported in the annual reports of the parent company itself.
  • For example, ViiV Healthcare (whose partners include Pfizer and Shionogi) operates as a subsidiary of GSK, so sales for ViiV’s Triumeq have been attributed to GSK.
  • Similarly, Xtandi is attributed to Astellas not Pfizer and Imbruvica is attributed to AbbVie rather than Johnson & Johnson.
  • Finally, sales of Eliquis are reported separately by both Bristol-Myers Squibb and Pfizer and so appears twice in the top product ranking, as does Enbrel with sales as reported by Amgen and Pfizer.

Therapy area sales

  • The sales data provided are not indication-specific where drugs are approved, or in development, for multiple indications. Instead they’re based on GlobalData’s Key Therapy Area classification, which places products into a single therapeutic area based on its corporate positioning and/or mechanism of action.
  • However, product sales may contribute to more than one sales segment, eg biologics and oncology, in which can sales segments for a company may add up to more than its total sales.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics